Methods: A 24-week quasi-experimental retrospective study including adults with T2DM and obesity (BMI 30 kg/m) who were treated with either daily-oral or weekly-subcutaneous semaglutide
It is important to recognise that whilst GLP-1 medications can facilitate healthier food choices, they work most effectively when combined with appropriate dietary modifications and lifestyle changes
If both are denied or unaffordable, compounded semaglutide at $199/month makes long-term treatment realistic
These shots are typically quick and easy to administer, and they can benefit individuals who have difficulty absorbing B12 from food or supplements
P., Fouquerel, E., & Opresko, P
The SYNCHRONIZE-1 trial evaluated survodutides safety and efficacy in adults with overweight or obesity, excluding those with type 2 diabetes